Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.

Toffoli B, Zennaro C, Winkler C, Giordano Attianese GMP, Bernardi S, Carraro M, Gilardi F, Desvergne B.

Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1154-F1165. doi: 10.1152/ajprenal.00198.2017. Epub 2018 Feb 28.

PMID:
29488390
2.

TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.

Bernardi S, Toffoli B, Tisato V, Bossi F, Biffi S, Lorenzon A, Zauli G, Secchiero P, Fabris B.

Clin Sci (Lond). 2018 Jan 5;132(1):69-83. doi: 10.1042/CS20171221. Print 2018 Jan 16.

PMID:
29167318
3.

Delayed Hair Follicle Morphogenesis and Hair Follicle Dystrophy in a Lipoatrophy Mouse Model of Pparg Total Deletion.

Sardella C, Winkler C, Quignodon L, Hardman JA, Toffoli B, Giordano Attianese GMP, Hundt JE, Michalik L, Vinson CR, Paus R, Desvergne B, Gilardi F.

J Invest Dermatol. 2018 Mar;138(3):500-510. doi: 10.1016/j.jid.2017.09.024. Epub 2017 Sep 28.

PMID:
28964716
4.

Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients.

Bernardi S, Toffoli B, Bossi F, Candido R, Stenner E, Carretta R, Barbone F, Fabris B.

BMC Nephrol. 2017 Jul 6;18(1):219. doi: 10.1186/s12882-017-0625-3.

5.

Association between thyroid hormones and TRAIL.

Bernardi S, Bossi F, Toffoli B, Giudici F, Bramante A, Furlanis G, Stenner E, Secchiero P, Zauli G, Carretta R, Fabris B.

Clin Biochem. 2017 Nov;50(16-17):972-976. doi: 10.1016/j.clinbiochem.2017.05.011. Epub 2017 May 25.

6.

Nephropathy in Pparg-null mice highlights PPAR╬│ systemic activities in metabolism and in the immune system.

Toffoli B, Gilardi F, Winkler C, Soderberg M, Kowalczuk L, Arsenijevic Y, Bamberg K, Bonny O, Desvergne B.

PLoS One. 2017 Feb 9;12(2):e0171474. doi: 10.1371/journal.pone.0171474. eCollection 2017.

7.

Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.

Toffoli B, Fabris B, Bartelloni G, Bossi F, Bernardi S.

Mediators Inflamm. 2016;2016:6529728. doi: 10.1155/2016/6529728. Epub 2016 Dec 14.

8.

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease.

Bernardi S, Bossi F, Toffoli B, Fabris B.

Biomed Res Int. 2016;2016:1752854. doi: 10.1155/2016/1752854. Epub 2016 Apr 21. Review.

9.

Aldosterone effects on glomerular structure and function.

Bernardi S, Toffoli B, Zennaro C, Bossi F, Losurdo P, Michelli A, Carretta R, Mulatero P, Fallo F, Veglio F, Fabris B.

J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):730-8. doi: 10.1177/1470320315595568. Epub 2015 Aug 17.

10.

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes.

Bernardi S, Fabris B, Thomas M, Toffoli B, Tikellis C, Candido R, Catena C, Mulatero P, Barbone F, Radillo O, Zauli G, Secchiero P.

Mol Cell Endocrinol. 2014 Aug 25;394(1-2):13-20. doi: 10.1016/j.mce.2014.06.004. Epub 2014 Jul 3.

PMID:
24998520
11.

The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40.

Secchiero P, Toffoli B, Melloni E, Agnoletto C, Monasta L, Zauli G.

Acta Diabetol. 2013 Dec;50(6):899-906. doi: 10.1007/s00592-013-0476-8. Epub 2013 Apr 25.

PMID:
23615706
12.

Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB.

Tisato V, Toffoli B, Monasta L, Bernardi S, Candido R, Zauli G, Secchiero P.

Clin Nutr. 2013 Apr;32(2):259-64. doi: 10.1016/j.clnu.2012.07.003. Epub 2012 Jul 26.

PMID:
22840561
13.

Potential role of TRAIL in the management of autoimmune diabetes mellitus.

Bernardi S, Norcio A, Toffoli B, Zauli G, Secchiero P.

Curr Pharm Des. 2012;18(35):5759-65. Review.

PMID:
22726118
14.

Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).

Bernardi S, Burns WC, Toffoli B, Pickering R, Sakoda M, Tsorotes D, Grixti E, Velkoska E, Burrell LM, Johnston C, Thomas MC, Fabris B, Tikellis C.

Clin Sci (Lond). 2012 Jul;123(1):29-37. doi: 10.1042/CS20110403.

PMID:
22288735
15.

Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma.

Bernardi S, Zennaro C, Palmisano S, Velkoska E, Sabato N, Toffoli B, Giacomel G, Buri L, Zanconati F, Bellini G, Burrell LM, De Manzini N, Fabris B.

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):202-9. doi: 10.1177/1470320311426023. Epub 2011 Nov 2.

PMID:
22048948
16.

High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage.

Bernardi S, Toffoli B, Zennaro C, Tikellis C, Monticone S, Losurdo P, Bellini G, Thomas MC, Fallo F, Veglio F, Johnston CI, Fabris B.

Nephrol Dial Transplant. 2012 May;27(5):1793-800. doi: 10.1093/ndt/gfr600. Epub 2011 Oct 29.

PMID:
22036945
17.

Osteoprotegerin promotes vascular fibrosis via a TGF-╬▓1 autocrine loop.

Toffoli B, Pickering RJ, Tsorotes D, Wang B, Bernardi S, Kantharidis P, Fabris B, Zauli G, Secchiero P, Thomas MC.

Atherosclerosis. 2011 Sep;218(1):61-8. doi: 10.1016/j.atherosclerosis.2011.05.019. Epub 2011 May 27.

PMID:
21679949
18.

Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes.

Fischetti F, Candido R, Toffoli B, Durigutto P, Bernardi S, Carretta R, Tedesco F, Fabris B.

Atherosclerosis. 2011 May;216(1):83-9. doi: 10.1016/j.atherosclerosis.2011.01.050. Epub 2011 Mar 1.

PMID:
21367419
19.

TRAIL shows potential cardioprotective activity.

Toffoli B, Bernardi S, Candido R, Zacchigna S, Fabris B, Secchiero P.

Invest New Drugs. 2012 Jun;30(3):1257-60. doi: 10.1007/s10637-010-9627-8. Epub 2011 Jan 4.

PMID:
21197620
20.

Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system.

Fabris B, Candido R, Bortoletto M, Toffoli B, Bernardi S, Stebel M, Bardelli M, Zentilin L, Giacca M, Carretta R.

J Hypertens. 2011 Feb;29(2):273-81. doi: 10.1097/HJH.0b013e328340d0d3.

PMID:
21107282
21.

Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets.

Toffoli B, Bernardi S, Candido R, Sabato N, Carretta R, Corallini F, Secchiero P, Zauli G, Fabris B.

Mol Cell Endocrinol. 2011 Jan 1;331(1):136-42. doi: 10.1016/j.mce.2010.08.019. Epub 2010 Sep 9.

PMID:
20832449
22.

Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.

Bernardi S, Candido R, Toffoli B, Carretta R, Fabris B.

Nephrol Dial Transplant. 2011 Mar;26(3):832-8. doi: 10.1093/ndt/gfq524. Epub 2010 Sep 1.

PMID:
20810455
23.

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C.

Circ Res. 2010 Oct 1;107(7):888-97. doi: 10.1161/CIRCRESAHA.110.219279. Epub 2010 Jul 29.

PMID:
20671240
24.

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes.

Zauli G, Toffoli B, di Iasio MG, Celeghini C, Fabris B, Secchiero P.

Diabetes. 2010 May;59(5):1261-5. doi: 10.2337/db09-1771. Epub 2010 Feb 25.

25.

Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo.

Candido R, Toffoli B, Corallini F, Bernardi S, Zella D, Voltan R, Grill V, Celeghini C, Fabris B.

J Vasc Res. 2010;47(3):252-61. doi: 10.1159/000257339. Epub 2009 Nov 11.

26.

Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.

Cocchietto M, Zorzin L, Toffoli B, Candido R, Fabris B, Stebel M, Sava G.

Diabetes Metab. 2008 Dec;34(6 Pt 1):587-94. doi: 10.1016/j.diabet.2008.05.009. Epub 2008 Oct 15.

PMID:
18926757
27.

Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.

Fabris B, Candido R, Bortoletto M, Zentilin L, Sandri M, Fior F, Toffoli B, Stebel M, Bardelli M, Belgrado D, Giacca M, Carretta R.

J Hypertens. 2007 Jul;25(7):1481-90.

PMID:
17563572
28.

Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.

Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, Rimondi E, Fabris B, Giacca M, Zauli G.

Circulation. 2006 Oct 3;114(14):1522-30. Epub 2006 Sep 25.

PMID:
17000905

Supplemental Content

Loading ...
Support Center